Prevalence and socio-demographic factors associated with non-protective immunity against tetanus among high school adolescents girls in Nigeria
© Orimadegun et al.; licensee BioMed Central Ltd. 2014
Received: 17 September 2013
Accepted: 10 March 2014
Published: 17 March 2014
The low uptake of tetanus vaccine and its resultant high burden of tetanus in Nigeria suggest the need to improve routine and booster vaccination in children and adolescents. However, epidemiological evidence for vaccination in the adolescent age group needed for effective strategy and policy formulation is lacking. This study was carried out to determine the prevalence of protective immunity against tetanus and to identify risk factors for non-protective immunity among schooling adolescents.
Using a three-stage sampling technique, 851 female adolescents were randomly selected from secondary schools in Ibadan, Nigeria. A pre-tested questionnaire was used to obtain data on demographic and socio-economic characteristics and history of tetanus vaccination. An immuno-chromatographic rapid test kit, “Tetanos Quick Stick” was used to test specific anti-tetanus antibody protective level in venous blood samples. Descriptive statistics, Chi-square and logistic regression analyses were done with level of significance set at p = 0.05.
Mean age of participants was 14.3 ± 1.9 years. Seroprevalence of protective immunity against tetanus was 38.1% and it significantly decreased with increasing age. More adolescents in public (65.4%) than private (44.7%) schools had non-protective level of immunity. A significantly increasing trend in the risk of non-protective immunity was observed with decreasing level of mothers’ education. Also, the Odds of non-protective level of immunity was significantly higher in public than private schools (OR = 2.14; 95% CI =1.39, 3.20) but lower among adolescents who had history of recent tetanus toxoid injection than those who did not (OR = 0.11 95% CI = 0.09, 0.22). However, no significant association was found between protective immunity against tetanus and parents’ marital status as well as family size.
Protective immunity against tetanus among female adolescents was poor, more so in public schools and those who had not received vaccination a year prior to the study. Policy-makers need to consider the inclusion of immunization against tetanus in the school health programme.
Tetanus is one of the leading causes of death among hospitalised children in Nigeria especially in the neonatal age group. It accounts for about 13.6% of all child deaths and 26.4% of deaths in the neonatal age group in Ibadan, Nigeria . Nigeria is one of the 16 countries in the African region with the highest numbers of neonatal deaths, accounting for 90% global neonatal tetanus cases . Currently, only an estimated 47% of Nigerian infants receive the third dose of Diphtheria-Pertusis-Tetanus (DPT) vaccine and about 60% of women of child-bearing age have protective level of immunity against tetanus . The slow pace of the uptake of health interventions by women of child-bearing age, 15 to 45 years, particularly vaccination against tetanus makes the elimination of tetanus unrealistic in the near future [4, 5].
Neonatal tetanus is preventable. The World Health Organization (WHO) recommends that women of child-bearing age, should commence a 5-dose regimen of vaccination against tetanus as early as possible [6–8]. This comprises; first dose given at any time during the ages 15 to 45 years, a second dose four weeks later and a third dose given 6–12 months after the first two doses. Additional two doses, given at least one year apart further prolong the duration of immunity against tetanus. A previous study has shown that after the fifth dose, protective antibody levels may last for about 20 years  with resultant protection for the mother and her newborn who would be sufficiently protected against tetanus .
Though Nigeria started routine immunization against tetanus since 1979, there is no known programme aimed at ensuring that the recommended five doses of tetanus toxoid are given to adolescent girls before their first pregnancy. The current neonatal tetanus prevention programme principally focuses on giving only pregnant women two doses of tetanus toxoid injections during antenatal care (ANC) leaving out a large number who may not book at health facilities where vaccinations are provided . The 2008 Nigeria Demographic Health Survey  showed that less than half of the eligible pregnant women get vaccinated. This is mainly due to the fact that a large number of pregnant women did not book for antenatal care where the vaccine was available and only about 35% of the women delivered in health facilities . The female adolescents, especially those in schools, constitute a considerable number of the women in the child-bearing age and they could provide opportunity for delivering tetanus vaccination to prospective mothers. However, Nigeria has no formal or structured health system that caters for the adolescent population in place and the current immunization policy  does not sufficiently address vaccination for the adolescents. Thus, a significant proportion of eligible women of child-bearing ages neither receive vaccination against tetanus before nor during pregnancy thereby putting them and their newborns at risk of tetanus. The only study that has assessed tetanus immunity among Nigerian adolescents was conducted almost about 20 years ago . Brabin and Colleagues determined tetanus antibody seropositivity in adolescent girls from Nigeria as part of a multinational study and 54.7% of adolescent girls were reported as seronegative . In that study, data from Nigeria were obtained among adolescents living in rural communities of Port Harcourt, South-eastern Nigeria. The authors proposed that booster vaccination in early adolescence may protect women in their reproductive ages .
Two recent studies demonstrated some socio-demographic factors associated with uptake of vaccines in infancy and early childhood but not adolescents [4, 5]. Brown and Oluwatosin  showed that maternal education (secondary school or more), being married and living in urban areas of Nigeria were associated with improved immunization among children aged 12–24 months. Antia  also reported that “the woman being the sole provider for her family was associated with a higher likelihood of fully immunizing the child” in Nigeria. The question of, what socio-demographic factors distinguish female adolescents with non-protective level of immunity from those without, remains unanswered in published literature. In view of this, the present study was conducted to evaluate immunity against tetanus among adolescent girls with a view to providing evidence for or against the practicability of tetanus immunization in this age group in Nigeria.
Study design and setting
This study was cross-sectional in design. It involved adolescent girls selected from secondary schools, who were residents of Ibadan North Local Government Area (IBNLGA), Nigeria. The IBNLGA has a population of 306,795 , mainly Yoruba-speaking people and has urban and slum communities. These communities are divided into twelve geo-political wards, defined on the basis of the populations and contiguity of communities. This study was conducted between June and August, 2012. There were 28 public and 32 private registered secondary schools in IBNLGA as at the time of this study.
Study population and sampling method
Sample size justification
It was postulated that the prevalence of protective immunity against tetanus among school girls was 45.3% based on the report by Brabin and colleagues . Using the formula for estimating sample size for cross sectional study, 381 was calculated as the minimum number of participants required at 95% level of confidence. A design effect factor of 2 was assumed, the estimated sample size was multiplied by 2 giving a total of 762 participants as minimum sample size . However, post-hoc power calculation revealed that using an effect size of 5%, enrolling 851 adolescent girls gave a study power of over 80% at the same level of confidence.
Instruments and data collection procedure
A questionnaire developed for the purpose of this study was pre-tested in two secondary schools located outside IBNLGA. Thereafter the instrument was revised to ensure construct validity. Tetanos Quick Stick (TQS) (Gamma, Angleur, Belgium), a validated immunochromatographic test [15–17] was carried out on each participants by one of the investigators. The questionnaire contained information on socio-demographics, tetanus immunization history and previous tetanus infection in ≤1 year. Those who tested negative to TQS were referred to the nearest primary health centre within IBNLGA for tetanus toxoid vaccination.
Data obtained were analysed using SPSS for Window 17.0 (SPSS, Inc., Chicago, IL USA). Participants’ socio-economic class scores were determined based on the occupations and educational attainments of the parents using the classification method earlier reported by Oyedeji . This method determines the mean of scores from education and occupation of both parents and rounded up to the nearest whole number. The number thus obtained was the social class assigned to the child. In this study, score of 1 point was assigned upper class; 2 and 3 points were grouped as middle class while 4 and 5 points were regarded as lower class. Prevalence of non-protective immunity was calculated for the different participants’ characteristics. Bivariate analysis was done using the Chi-square test for associations. Logistic regression was used to determine independent predictors of non-protective immunity against tetanus among factors that were found to be significant at bivariate analyses level. The possible interaction between age and school types was also assessed by including the interaction term in the model. The odds of non-protective immunity for various variables were assessed using Odd Ratios (OR) and 95% Confidence Intervals (CI) at p = 0.05.
Approval to carry out the study was obtained from the Oyo State Ministry of Health Research Ethical Review Committee (reference number: AD 13/479/215). Written informed consent was obtained from each of the participant’s parents or guardians after the purpose of the study was explained to each of them in the language they understood, mainly Yoruba. Also, a written permission to conduct the study was also obtained from the State Commissioner of Education while the Principals of the selected schools were met to obtain their verbal permission as well. Serial numbers and codes were used to identify participants and schools. The participants were assured that their responses would not be reported individually but as part of an overall study report or scientific publications.
Demographic characteristics of participants
There were 851 participants; 710 (83.4%) and 141 (16.6%) adolescents from public and private schools, respectively. Most of the participants (90.1% in private and 90.4% in public schools), belong to the Yoruba ethnic group while others were non-Yoruba (51 Ibos, 25 Hausas, 4 Urhobo and 2 Efik). Majority (86.0%) of the participants were from homes where parents were living together, while few (2.0%) had single parents. Those from families with more than four children were 88.5%. Others were from families with four or fewer children. Almost two-thirds (62.4%) of participants were in the range of 2nd to 4th born of their mothers, while 28.8% were 1st born and the others were beyond the 4th position (8.8%) among mother’s children.
Demographic characteristics of adolescents in private and public schools in Ibadan, Nigeria
All participants (851)
Public Sschools (710)
Private schools (141)
Parents marital status
Married living with spouse
Number of mother’s children
1 – 4
Position among mother’s children
2nd to 4th
Tetanus immunization history
Only 39 (4.6%) of the participants received tetanus immunization in the one year prior to the study; of this, 9 (23.1%) were in private schools and 30 (76.9%) in public schools. Majority (65.4%) of the 39 mentioned “wound/injury” as the reason for being given tetanus toxoid injection. Participants who had received tetanus toxoid injections: 16 (41.1%), 10 (25.6%), 8 (20.5%) and 5 (12.8%) were given at primary health centres, private clinics or hospitals, mission hospitals and patent medicine stores respectively. However, only 282 (33.1%) out of the 851 could produce their immunization cards.
Prevalence and risk of non-protective immunity against tetanus
Prevalence of protective immunity against tetanus by mothers’ education
Mother level of education
Level tetanus immunity
OR (95% CI)
No formal education
1.39 (0.52, 3.69)
Modern 3 and Primary 6 Certificate
1.52 (0.93, 2.50)
Secondary School or Grade II certificate
1.79 (1.25, 2.56)
Post-Secondary certificate, not University
1.69 (1.17, 2.43)
Seroprevalence of tetanus immunity by socioeconomic class
Level of tetanus immunity
OR (95% CI)
0.85 (0.59, 1.23)
0.86 (0.59, 1.25)
Prevalence of tetanus immunity by parents’ marital status, Ethnicity, family size, and tetanus immunization history
Level tetanus immunity
UOR (95% CI)
AOR (95% CI)
1.21 (1.09, 2.52)
1.09 (1.02, 3.07)
Type of school
• Public schools
2.34 (1.62, 3.37)
2.14 (1.39, 3.20)
• Private schools
Parents marital status
• Single parents
1.54 (0.54, 4.41)
1.28 (0.31, 4.12)
• Married living with spouse
1.34 (0.86, 2.08)
1.13 (0.49, 2.47)
No. of mother’s children
• 1 – 4
0.97 (0.63, 1.49)
0.55 (0.34, 1.91)
• 2nd – 4th
1.13 (0.83, 1.54)
1.09 (0.84, 1.53)
• Beyond 4th
1.28 (0.74, 2.19)
1.16 (0.57, 2.09)
History of recent TT injection
0.12 (0.05, 0.28)
0.11 (0.09, 0.22)
Age and Type of schoolb
1.01 (0.69, 1.18)
Also, regarding the number of mother’s children, the odds for non-protective immunity among participants whose number of mother’s children were 1 to 4 than those > 4 (adjusted OR = 0.55; 95% CI = 0.34, 1.91) was not significantly different from others (p = 0.966). Moreover, the odds of non-protection for tetanus immunity for those who were in the 2nd – 4th positions (adjusted OR = 1.09; 95% CI = 0.84, 1.53) and beyond the 4th position (adjusted OR = 1.16; 95% CI = 0.57, 2.09) were not significantly different from those who are first. About eighteen percent (17.9%) of the participants who did received recent tetanus toxoid injection had non-protective immunity compared to 63.9% of those who had no history of recent tetanus toxoid injection (p < 0.001). The risk of non-protective immunity in the group with recent history of tetanus toxoid injection was significantly lower than those who gave no history of recent tetanus injection (adjusted OR = 0.11; 95% CI = 0.09, 0.22). Though an association was found between age and school types, there is no interaction between the effects of these two explanatory variables when a model with an interaction term between age (in years) and school types (private or public) was fitted.
This study revealed that the prevalence of protective immunity against tetanus among adolescent girls was 38.1%, about two-third of the participants had non-protective level of immunity, more adolescent in private than public schools were protected against tetanus, prevalence of protection against tetanus decreased with increasing age and mothers who have at least tertiary education were more likely to have female adolescents with protective immunity against tetanus than others. The obvious implication of the low prevalence of protective immunity against tetanus is that most of the participants probably received neither tetanus toxoid injection nor any effective tetanus vaccination many years after infancy. Only 3.1% claimed they had tetanus injections for various reasons within one year prior to the study.
The prevalence obtained from the present data is lower than 45.3% earlier reported in a multinational study involving girls selected from a rural community of Port Harcourt, Nigeria . However, apart from the fact that those girls who participated in the study by Brabin and Colleagues  were selected from rural community, Enzyme-linked immunosorbent assay (ELISA) method was used to determine tetanus antibody level against TQS used the present study. Also the prevalence of protective immunity against tetanus in the present study is far lower than 88.9% reported by Dinelli et al.,  among female adolescents in Brazil. Again, ELISA method was used in that study. Unlike the female adolescents who participated in the current study, all the Brazilian female adolescents were recently immunised against tetanus. A study in Turkey had attributed a high prevalence of protective immunity against tetanus to the success of Expanded Programme on Immunization, which recommends two booster doses of tetanus vaccine after infancy including a second dose during adolescence . It is worth noting that only about a third of the participants in our study, produced immunization cards and only a small proportion of the adolescents had received immunization within a year prior to the study. Therefore, it is difficult to make any valid comparisons between the data from Turkey  and Ibadan, Nigeria. It is also difficult to compare findings from the present study with others in the literature because many of these studies investigated prevalence of tetanus immunity in adults and none was carried out in the adolescent population [21–23].
Another important finding from the present study was that the prevalence of protective immunity against tetanus decreased with increasing age among the adolescent population. Naturally, immunity against tetanus declines with time. Individuals require multiple doses to attain protection against tetanus and three doses of tetanus toxoid given to infants as part of DPT only confer protection till about the age of 5 years, it is not unexpected that by adolescence very few will have detectable level of immunity against tetanus . The highest level of immunity was observed in the younger segments of the population, who may have been covered by routine immunization. The implication of extremely low tetanus immunity towards the end of adolescence is that most women will enter child-bearing age with little or no protection. This may explain the high burden of maternal and neonatal tetanus currently being experienced in Nigeria.
The difference in the seroprevalence of protective immunity against tetanus between private and public schools was not surprising, most private schools are largely populated by children from high socioeconomic class of the society and their vaccine uptakes are likely to be better than those from lower socioeconomic status [25, 26]. However, when the female adolescents who participated in the study were stratified by their parents’ socio-economic class there was no significant association between seroprevalence of protective immunity against tetanus and socio-economic class. This finding is in keeping with the findings by Inandi and colleagues  which showed that there was no association between immunity against tetanus and socioeconomic status among children in Turkey. Moreover, just as in the report by Inandi and colleagues , the present study also demonstrated an increased risk of low immunity against tetanus in female adolescents whose parents were less educated. It was also observed from this study that there was no association between protective immunity against tetanus and recent history of tetanus toxoid injection. Only a few of the participants gave history of recent tetanus toxoid injection. Immediate and long-term responses to tetanus toxoid injection depend on individual’s previous immunity. Regarding the association between maternal level of education and prevalence of protective immunity among participants, there is no conceivable biological explanation for the lowest protective immunity found among adolescents in the groups of mothers with secondary or post-secondary certificates.
This study has provided data that may influence child health and clinical practice. Among other reasons, the persistence of tetanus as the cause of high proportion of deaths among Nigerian children in spite of availability of vaccines and past efforts made towards immunization against tetanus and the high fatality rate (over 50%) of tetanus underscores the need to assess the effectiveness and extent of protection among adolescent population. Universal immunization of school adolescents is one of the promising strategies that may reduce the burden of tetanus in countries. However, the current Nigerian healthcare system appears not suitably structure to deliver such service. Though this approach is currently been employed in the fight against vitamin A deficiency as well as polio and it appears to be yielding promising results . To apply the same approach in the reduction of tetanus burden in Nigeria, there is the need to further assess its acceptability among school children and their caregivers including parents and teachers.
Two important factors limit the generalisability and interpretations of findings from this research. First, the fact that those female adolescents who participated in this study were recruited from the metropolitan area of Ibadan and from schools may limit the generalisation of the findings to those in rural area and other parts of Nigeria. One can only speculate that the poor protective level of immunity may be worse in the rural and hard-to-reach communities in Nigeria. Second, the TQS gives semi-quantitative assessment of immunity level, thereby restricting further stratification of protection level or lack of it in the study population.
This study has shown that the prevalence of non-protective level of immunity against tetanus among Nigeria adolescent girls is high. Age and types of school are important factors to be considered in tackling the menace of low tetanus protection among women of reproductive age. Specific plans of action need to be developed to reach the adolescents population of urban areas. Given the multifaceted challenges inherent in health programmes, an inter-sectorial approach is necessary. For instance, efforts should be made in the existing health facilities to use any contact with eligible adolescents as an opportunity to immunise against tetanus. The need to commence school-based immunization campaign against tetanus for female adolescents in Nigeria is also suggested.
We are grateful to all the adolescents who participated in the study. We also thank house physicians and research assistants for their help.
- Ayoola OO, Orimadegun AE, Akinsola AK, Osinusi K: A five-year review of childhood mortality at the University College Hospital, Ibadan. West Afr J Med. 2005, 24: 175-179.PubMedGoogle Scholar
- WHO: Why Maternal and Neonatal Tetanus elimination?. Maternal and Neonatal Tetanus (MNT) elimination. 2012, http://www.afro.who.int/en/nigeria/nigeria-publications/1934-maternal-and-neonatal-tetanus-elimination.html (accessed 4th July, 2012)Google Scholar
- UNICEF: Table 3: Health. Book Table 3: Health (Editor ed.^eds.). 2013, City: United Nations Children’s Fund (UNICEF), 108-111.Google Scholar
- Brown VB, Oluwatosin OA: Socio-demographic factors associated with childhood immunization uptake in Akinyele Local Government Area, Oyo State, Nigeria. Afr J Med Med Sci. 2012, 41: 161-167.PubMedGoogle Scholar
- Antai D: Gender inequities, relationship power, and childhood immunization uptake in Nigeria: a population-based cross-sectional study. Int J Infect Dis. 2012, 16: e136-145.View ArticlePubMedGoogle Scholar
- WHO: Maternal and Neonatal Tetanus (MNT) elimination - The Strategies. http://www.who.int/immunization/diseases/MNTE_initiative/en/index2.html (accessed 2 February, 2012)
- WHO/UNICEF/UNFPA: Maternal and Neonatal Tetanus Elimination by 2005: Strategies for achieving and maintaining elimination. 2000, http://www.unicef.org/health/files/MNTE_strategy_paper.pdf (accessed 2 February, 2012)Google Scholar
- WHO: Tetanus vaccine - WHO position paper. Wkly Epidemiol Rec. 2006, 81: 197-208.Google Scholar
- Blencowe H, Lawn J, Vandelaer J, Roper M, Cousens S: Tetanus toxoid immunization to reduce mortality from neonatal tetanus. Int J Epidemiol. 2010, 39 (Suppl 1): i102-i109.PubMed CentralView ArticlePubMedGoogle Scholar
- Federal Ministry of Health (FMOH): National immunization policy. 2009, National Primary Health Care Development Agency, Federal Ministry of Health. 2009, AbujaGoogle Scholar
- National Population Commission (NPC) [Nigeria] and ICF Macro: Nigeria Demographic and Health Survey 2008. 2009, Abuja, NigeriaGoogle Scholar
- Brabin L, Fazio-Tirrozzo G, Shahid S, Agbaje O, Maxwell S, Broadhead R, Briggs N, Brabin B: Tetanus antibody levels among adolescent girls in developing countries. Trans R Soc Trop Med Hyg. 2000, 94: 455-459. 10.1016/S0035-9203(00)90139-1.View ArticlePubMedGoogle Scholar
- National Population Commission: Population Census. 2006 Official gazette of the National Bureau of Statistics, Abuja, Nigeria. http://www.nigerianstat.gov.ng (accessed: 23 May, 2012)
- Kirkwood BR, Sterne JAC: Calculation of required sample size - Adjustment for cluster designs. Essential Medical Statistics. 2003, Oxford: Blackwell Publishing LTD, 423-424. 2Google Scholar
- Elkharrat D, Sanson-Le-Pors MJ, Arrouy L, Beauchet A, Benhamou F: Evaluation of a bedside immunotest to predict individual anti-tetanus seroprotection: a prospective concordance study of 1018 adults in an emergency department. Emerg Med J. 2010, 27: 36-42. 10.1136/emj.2008.068254.View ArticlePubMedGoogle Scholar
- Stubbe M, Mortelmans LJ, Desruelles D, Swinnen R, Vranckx M, Brasseur E, Lheureux PE: Improving tetanus prophylaxis in the emergency department: a prospective, double-blind cost-effectiveness study. Emerg Med J. 2007, 24: 648-653. 10.1136/emj.2007.048520.PubMed CentralView ArticlePubMedGoogle Scholar
- Orimadegun AE, Orimadegun BE, Adepoju AA: Immunity against tetanus infection, risk factors for non-protection and validation of a rapid immunotest kit among hospitalised children in Nigeria. Front Neurol. 2013, 4: 142-doi:10.3389/fneur.2013.00142PubMed CentralView ArticlePubMedGoogle Scholar
- Oyedeji GA: Socio-economic and Cultural Background of Hospitalised Children in Ilesha. Nig J Paed. 1985, 12: 111-117.Google Scholar
- Dinelli MI, Fisberg M, de Moraes-Pinto MI: Tetanus and diphtheria immunity in adolescents from Sao Paulo, Brazil. Braz J Med Biol Res. 2007, 40: 259-263. 10.1590/S0100-879X2006005000071.View ArticlePubMedGoogle Scholar
- Caglar K, Karakus R, Aybay C: Determination of tetanus antibodies by a double-antigen enzyme-linked immunosorbent assay in individuals of various age groups. Eur J Clin Microbiol Infect Dis. 2005, 24: 523-528. 10.1007/s10096-005-1372-0.View ArticlePubMedGoogle Scholar
- Gergen PJ, McQuillan GM, Kiely M, Ezzati-Rice TM, Sutter MS, Virella G: A population based serologic survey of immunity to tetanus in the United State. New Engl J Med. 1995, 332: 761-776. 10.1056/NEJM199503233321201.View ArticlePubMedGoogle Scholar
- McQuillan GM, Moran DK, Deforest A, Chu SY, Wharton M: Serelogic immunity to diphtheria and tetanus in United States. Ann Intern Med. 2002, 136: 660-666. 10.7326/0003-4819-136-9-200205070-00008.View ArticlePubMedGoogle Scholar
- Redwan E-RM, Al-Awady MK: Prevalence of tetanus immunity in the Egyptian population. Hum Antibodies. 2002, 11 (1): 55-59.Google Scholar
- Ray B, Balmer P, Roper MH: Immunological basis for immunization - Module 3: Tetanus (Revision). http://whqlibdoc.who.int/publications/2007/9789241595551_eng.pdf. (accessed15 March, 2012)
- Masand R, Dixit AM, Gupta RK: Study of immunisation status of rural children (12–23 months age) of district Jaipur, Rajasthan and factors influencing it: a hospital based study. J Indian Med Assoc. 2012, 110: 795-799.PubMedGoogle Scholar
- Matthews Z, Diamond I: Child immunisation in Ghana: the effects of family, location and social disparity. J Biosoc Sci. 1997, 29: 327-343. 10.1017/S0021932097003271.View ArticlePubMedGoogle Scholar
- Inandi T, Ertekin V, Ayyildiz A: Sero-epidemiology of tetanus antibody among the children in eastern Turkey. Public Health. 2002, 116: 379-382. 10.1038/sj.ph.1900866.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.